Cagrilintide 5mg / 10mg
Also known as Cagri
Long-acting amylin analogue (5mg and 10mg vials, ≥98% purity) supplied as a lyophilised powder for in vitro receptor-binding and metabolic-signalling research.
Supplied as a lyophilised vial for you to reconstitute — use our calculator for your target concentration.
For In Vitro Use Only — Not for Human Use
Every batch is independently HPLC & mass-spec tested. Certificate of Analysis is batch-numbered and matched to the vial you receive.
Overview
Cagrilintide is a long-acting synthetic analogue of the pancreatic hormone amylin, engineered with a fatty-acid side chain that extends its plasma half-life relative to native amylin. Supplied in a 10mg lyophilised vial, it is prepared to ≥98% purity by RP-HPLC for laboratory use only.
Research
Cagrilintide is studied in vitro for its affinity across the amylin receptor family (AMY1R, AMY2R, AMY3R) and its calcitonin-receptor cross-reactivity. Research groups frequently pair Cagrilintide with GLP-1 analogues such as Semaglutide to model complementary metabolic pathways under controlled conditions.
